HomeInsightsMarket Capitalization

Market Capitalization of Concord Biotech Ltd

Market Capitalization of Concord Biotech Ltd

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Concord Biotech Ltd

NSE: CONCORDBIO

Market Cap

₹ 21253.3 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Concord Biotech Ltd is ₹ 21253 crore as of 22 Nov 24 .
  • The Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 15922 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Concord Biotech Ltd is ₹ 2031 as of 22 Nov 15:30 .
  • The Dividend Payouts of Concord Biotech Ltd is ₹ 8.75 as of Jun 21, 2024 .

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Company Fundamentals for Concord Biotech Ltd

No data available

Image

Concord Biotech Ltd

NSE: CONCORDBIO

Share Price

₹ 2031.55

43.00 (2.16%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242031.55
21 Nov 20241988.55
19 Nov 20241898.5
18 Nov 20241910.05
14 Nov 20241893.25
13 Nov 20241853.45
12 Nov 20241860.35
11 Nov 20241877.85
08 Nov 20241851.85
07 Nov 20241828.7

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Concord Biotech Ltd

No data available

No data available

Historical P/E Ratio of Concord Biotech Ltd

No data available

* All values are in %

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Image

Concord Biotech Ltd

NSE: CONCORDBIO

DIVIDENDPAYOUT

₹ 9

Last updated on: Jun 21, 2024

About Concord Biotech Ltd

  • Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based biopharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Concord Biotech Ltd News Hub

News

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 Novembe...

Read more

06 Nov 202409:53

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Concord Biotech Ltd Market Cap

What is the market cap of Concord Biotech Ltd?

As of November 22, 2024, Concord Biotech Ltd has a market capitalization of ₹21253.3, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Concord Biotech Ltd's market capitalization?

Concord Biotech Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Concord Biotech Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Concord Biotech Ltd's market capitalization change?

Concord Biotech Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*